Digirad to Introduce New Clinical Standard for Cardiac SPECT
January 25 2008 - 6:00AM
PR Newswire (US)
POWAY, Calif., Jan. 25 /PRNewswire-FirstCall/ -- Digirad
Corporation (NASDAQ:DRAD), a leading provider of medical diagnostic
imaging systems and services to physicians' offices, hospitals and
imaging centers, will showcase its latest work-in-progress during
ACC.08, the American College of Cardiology's 57th Annual Scientific
Session and Exposition to be held March 29-April 1, 2008, in
Chicago. Digirad's Cardius X-ACT(TM), a dedicated cardiac SPECT
system, is expected to set a new clinical standard with X-ACT
attenuation correction. The system uses the Cardius-3 XPO camera's
solid state detectors with an x-ray tube. The revolutionary X-ACT
approach exploits the high-count rate capabilities of solid-state
detectors and takes advantage of the full 24-inch-wide triple-head
detector geometry to eliminate truncation. The imaging system
offers the benefits of high precision, faster speed, low dose and
superb reliability. Digirad also recently released nSPEED, an
advanced three-dimensional SPECT image reconstruction technique.
This advanced algorithm provides clinicians with significant image
quality improvement over existing 2D reconstruction techniques by
producing images with better contrast and spatial resolution to
help improve physicians' interpretation confidence. nSPEED rapid
image-acquisition protocols have demonstrated equivalent diagnostic
quality for stress and rest images in half the acquisition time of
traditional 2D approaches while providing reliable function
quantitation measurements from gated stress images and reliable
quantitation of perfusion-defect severity on stress and rest
images. About Digirad Corporation Digirad provides diagnostic
medical imaging systems and services to physicians' offices,
hospitals and imaging centers for cardiac, vascular, and general
imaging applications. Digirad's Cardius XPO line of nuclear imaging
cameras use patented solid-state technology and unique multi
(single, dual, triple) head design for superior performance and
advanced features for sharper digital images, faster processing,
compact size, lighter weight for portability, ability to handle
patients up to 500 pounds, and improved patient comfort compared to
standard nuclear cameras. Digirad's 2020tc general-purpose nuclear
imager has a small footprint and may also be configured for fixed
or mobile use to supplement primary imaging. Digirad's installed
base of equipment exceeds 450 systems; in addition, a mobile fleet
of more than 120 nuclear and ultrasound imaging systems is being
used in 22 states, primarily in the eastern, midwestern and
southwestern United States. For more information, please visit
http://www.digirad.com/. Digirad(R), Digirad Imaging Solutions(R),
and Cardius(R) are registered trademarks of Digirad Corporation.
Forward Looking Statements Digirad cautions that statements
included in this press release that are not a description of
historical facts are forward looking statements. You can identify
these statements by the fact that they do not relate strictly to
historical or current facts and use words such as "anticipate,"
"estimate," "expect," "project," "intend," "plan," "believe" and
other words and terms of similar meaning in connection with future
operating, financial or product performance or events. Examples of
such statements include statements regarding features and
performance of the X-ACT and nSPEED systems, physician and patient
benefits. Actual performance and benefits results may differ
materially from those set forth in this press release due to risks
and uncertainties inherent in Digirad's business including, without
limitation, disruptions in business activities, suppliers, the use
of Digirad's camera systems by physicians, reliability, technical
issues, recalls, and other risks detailed in Digirad's filings with
the U.S. Securities and Exchange Commission, including Annual
Report on Form 10-K, Quarterly Reports on Form 10-Q, Form 8-K and
other reports. Readers are cautioned to not place undue reliance on
these forward looking statements, which speak only as of the date
hereof. All forward looking statements are qualified in their
entirety by this cautionary statement, and Digirad undertakes no
obligation to revise or update the forward looking statements
contained herein. DATASOURCE: Digirad Corporation CONTACT:
Investors, Dan Matsui, , or Media, Len Hall, , both of Allen &
Caron, +1-949-474-4300, for Digirad Corporation; or Randy
Weatherhead, Sr. Vice President of Sales and Marketing of Digirad
Corporation, +1-858-726-1600, Web site: http://www.digirad.com/
Copyright
Digirad (NASDAQ:DRAD)
Historical Stock Chart
From Jun 2024 to Jul 2024
Digirad (NASDAQ:DRAD)
Historical Stock Chart
From Jul 2023 to Jul 2024